Page last updated: 2024-11-02

pioglitazone and Necrobiosis Lipoidica

pioglitazone has been researched along with Necrobiosis Lipoidica in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Necrobiosis Lipoidica: A degenerative disease of the dermal connective tissue characterized by the development of erythematous papules or nodules in the pretibial area. The papules form plaques covered with telangiectatic vessels. More than half of the affected patients have diabetes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boyd, AS1

Other Studies

1 other study available for pioglitazone and Necrobiosis Lipoidica

ArticleYear
Treatment of necrobiosis lipoidica with pioglitazone.
    Journal of the American Academy of Dermatology, 2007, Volume: 57, Issue:5 Suppl

    Topics: Adult; Female; Humans; Necrobiosis Lipoidica; Pioglitazone; Thiazolidinediones; Treatment Outcome

2007